CN103784973B - Irf9基因在动脉粥样硬化中的功能及应用 - Google Patents
Irf9基因在动脉粥样硬化中的功能及应用 Download PDFInfo
- Publication number
- CN103784973B CN103784973B CN201410031570.7A CN201410031570A CN103784973B CN 103784973 B CN103784973 B CN 103784973B CN 201410031570 A CN201410031570 A CN 201410031570A CN 103784973 B CN103784973 B CN 103784973B
- Authority
- CN
- China
- Prior art keywords
- irf9
- ldlr
- mice
- gene
- atherosclerosis
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Landscapes
- Investigating Or Analysing Biological Materials (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
Claims (2)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410031570.7A CN103784973B (zh) | 2014-01-23 | 2014-01-23 | Irf9基因在动脉粥样硬化中的功能及应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410031570.7A CN103784973B (zh) | 2014-01-23 | 2014-01-23 | Irf9基因在动脉粥样硬化中的功能及应用 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN103784973A CN103784973A (zh) | 2014-05-14 |
CN103784973B true CN103784973B (zh) | 2015-08-19 |
Family
ID=50661305
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201410031570.7A Active CN103784973B (zh) | 2014-01-23 | 2014-01-23 | Irf9基因在动脉粥样硬化中的功能及应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN103784973B (zh) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107022572A (zh) * | 2016-02-01 | 2017-08-08 | 河北伊维沃生物科技有限公司 | Ldl受体基因敲除的基因工程仓鼠 |
CN114651785A (zh) * | 2022-03-28 | 2022-06-24 | 中山大学 | 一种基于PEDF/ApoE双基因敲除的非酒精性脂肪性肝炎小鼠模型构建方法及应用 |
-
2014
- 2014-01-23 CN CN201410031570.7A patent/CN103784973B/zh active Active
Also Published As
Publication number | Publication date |
---|---|
CN103784973A (zh) | 2014-05-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103784973B (zh) | Irf9基因在动脉粥样硬化中的功能及应用 | |
CN104365543A (zh) | 非酒精性脂肪性肝病合并病毒性肝炎小鼠模型的建立方法 | |
CN103784975B (zh) | Irf7基因在动脉粥样硬化中的功能及其抑制剂的应用 | |
CN103784971B (zh) | Irf3基因在动脉粥样硬化中的功能及其抑制剂的应用 | |
Kiama et al. | The morphology of the pecten oculi of the ostrich, Struthio camelus | |
CN104225627B (zh) | 白细胞免疫球蛋白样受体亚家族b成员4在治疗动脉粥样硬化中的功能和应用 | |
CN103784943B (zh) | Irf4基因在支架及内膜剥脱术后再狭窄中的功能和应用 | |
Lahnsteiner | Differences in immune components of blood, spleen and head kidney between diploid and auto-and allotriploid Salmonidae | |
CN104232732B (zh) | Mapk信号整合激酶2在治疗动脉粥样硬化中的功能和应用 | |
CN104258419A (zh) | 干扰素调节因子1基因在治疗动脉粥样硬化中的应用 | |
CN104198697B (zh) | 离心力和剪应力应答基因1(recs1)在治疗血管损伤后再狭窄中的功能和应用 | |
Warkentin | Environmental and developmental effects on external gill loss in the red-eyed tree frog, Agalychnis callidryas | |
CN103784945B (zh) | Irf3基因在支架及内膜剥脱术后再狭窄中的功能和应用 | |
CN104258395B (zh) | 核苷酸合成酶cad在治疗动脉粥样硬化中的功能和应用 | |
CN104225597A (zh) | Mapk信号整合激酶1在治疗动脉粥样硬化中的功能和应用 | |
CN104383561A (zh) | 信号调节蛋白1在治疗动脉粥样硬化中的功能和应用 | |
CN104324389B (zh) | 血液剪切力应答蛋白1在治疗动脉粥样硬化中的功能和应用 | |
CN103784961A (zh) | Irf9在支架及内膜剥脱术后再狭窄中的功能及其抑制剂的应用 | |
CN104324390B (zh) | Mindin基因在治疗动脉粥样硬化中的应用 | |
CN104324388A (zh) | 干扰素调节因子4基因在治疗动脉粥样硬化中的应用 | |
CN104258397A (zh) | Dickkopf-3在治疗动脉粥样硬化中的功能和应用 | |
CN104174010B (zh) | Shps1在治疗血管损伤后再狭窄中的功能和应用 | |
CN104383560A (zh) | 干细胞抗原-1在治疗动脉粥样硬化中的功能和应用 | |
CN104324389A (zh) | 血液剪切力应答蛋白1在治疗动脉粥样硬化中的功能和应用 | |
CN104324391A (zh) | Vinexinβ在治疗动脉粥样硬化中的功能和应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right |
Effective date of registration: 20191121 Address after: 430040 No.1, floor 1, No.17, eleven village, Changqing Garden, Dongxihu District, Wuhan City, Hubei Province (18) Patentee after: Wuhan Dafeng Biotechnology Co., Ltd Address before: 430072 Hubei Province, Wuhan city Wuchang District of Wuhan University Luojiashan Patentee before: WuHan University |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20191219 Address after: 430014 3119, floor 3, building 9, Guanggu science and technology port, 18 huashiyuan North Road, Donghu New Technology Development Zone, Wuhan City, Hubei Province Patentee after: Wuhan linyijia Gene Technology Co., Ltd Address before: 430040 No.1, floor 1, No.17, eleven village, Changqing Garden, Dongxihu District, Wuhan City, Hubei Province (18) Patentee before: Wuhan Dafeng Biotechnology Co., Ltd |
|
TR01 | Transfer of patent right | ||
CP03 | Change of name, title or address |
Address after: 430076 room 002, 16 / F, building D2, phase III, software new town, No. 8, Huacheng Avenue, Wuhan East Lake New Technology Development Zone, Wuhan, Hubei Province Patentee after: Wuhan Huikang Gene Technology Co.,Ltd. Address before: Room 3119, 3 / F, building 9, Guanggu science and technology harbor, 18 huashiyuan North Road, Donghu New Technology Development Zone, Wuhan City, Hubei Province, 430014 Patentee before: Wuhan linyijia Gene Technology Co.,Ltd. |
|
CP03 | Change of name, title or address |